-
-
-
-
-
-
-
Novocure (NVCR) Tops Q4 EPS by 19c ; Offers Guidance
-
-
-
-
-
-
-
Novocure (NVCR) Tops Q3 EPS by 9c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)
-
-
-
-
-
-
-
Novocure (NVCR) Tops Q1 EPS by 18c
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) and Novocure (NVCR) Report Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields
-
-
-
-
-
-
-
H.C. Wainwright Upgrades NovoCure Ltd. (NVCR) to Buy
-
-
-
-
-
-
435,281 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

